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Abstract
Introduction: Transvenous pacing is a relatively safe treatment with a low complication rate, but
serious thromboembolic complications have been reported to occur in 0.6% to 3.5% of cases.
Superior vena cava obstruction syndrome is generally an uncommon but serious complication
occurring in <0.1% of patients. However, when it occurs it carries with it significant morbidity and
mortality.
Case presentation: A 51-year-old lady with long history of DDD permanent pacemaker presented
following a mechanical fall. She had no obvious injuries, and was hemodynamically stable. General
examination revealed features suggestive of Superior vena caval obstruction which was later
confirmed by imaging. She was treated with long term oral anticoagulation with good clinical
improvement.
Conclusion: Superior vena cava obstruction in patients with transvenous pacing leads, although
rare, is a well recognized complication. With growing elderly population and increasing number of
procedures performed, more and more people with permanent pacemaker are likely to be
encountered in clinical practice. One should carefully look for thromboembolic complications during
follow-up in patients with transvenous pacemaker leads, as it has implications for future management
and carries significant morbidity and mortality.
Introduction
Although transvenous pacing is a relatively safe treatment
with a low complication rate [1], serious thromboembolic
complications have been reported to occur in 0.6% to 3.5%
of cases [2]. Superior vena cava obstruction [SVCO]
syndrome is generally an uncommon but serious complica-
tion occurring in <0.1% of patients [3-6]. Fortunately, most
patients remain asymptomatic and subclinical because of
the development of an adequate venous collateral circula-
tion. Venous obstruction often first becomes apparent
during pacemaker lead revision, when difficulty in passing
the new pacing lead is encountered. In this report, we
present a case of pacemaker associated superior vena caval
obstruction syndrome and a brief review of literature.
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This 51-year-old Caucasian lady presented following a
mechanical fall. Nine years previously she had had a DDD
permanent pacemaker implanted on her left hand side
for stokes adams attacks due to second degree atrio-
ventricular block. One year ago, she presented with her
pacemaker eroding through the skin and then had another
pacemaker implantation on right hand side. Old atrial
lead was extracted while ventricular lead could not be
extracted and was cut short to be left in situ.
This time she presented following a mechanical fall. On
examination, her vital signs were stable. General examina-
tion revealed a raised jugular venous pressure, distended
neck and chest veins and right arm swelling, consistent
with SVCO. She had no clubbing, lymphadenopathy, or
breast lumps. The rest of her systemic examination was
unremarkable.
Her chest X-ray showed the pacemaker leads in situ
(Figure 1). Computer tomography scan (Figures 2-6)
Figure 1 (top) & 2 (bottom). Patient photographs showing
pacemaker and dilated veins.
Figures 3 & 4. Anterior-posterior (Figure 3, top)
and oblique (Figure 4, bottom) three dimensional
volume-rendered images from a contrast enhanced
computed tomographic scan demonstrating numerous
dilated superficial chest veins over the left chest.
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of underlying malignancy. She was treated with low
molecular weight heparin followed by long term oral
anticoagulation with warfarin. She was subsequently seen
in the cardiology clinic eight weeks later for further
evaluation. By this time signs of SVCO have improved
and discussions with the cardiothoracic surgeons a
decision was made that vascular intervention was not
warranted and that she should continue with long term
anticoagulation.
Discussion
There are variable reports about the incidence of venous
obstruction after pacing lead implantation ranging from
0.6% to 30% [7,8]. Much of this difference can be
explained on the basis of differences in definition. Despite
relatively high incidence of documented venous obstruc-
tion, most patients remain asymptomatic because of the
development of an adequate venous collateral circulation
[4-6]. In contrast to an incidence of between 8% and 21%
of occlusion of the subclavian or brachiocephalic vein in
these studies, the incidence of pacemaker induced SVCO
syndrome is reported to be very low, at 0.03-0.4% [9,10].
Figure 5. Three dimensional volume-rendered images from
posterior aspect showing dilated and tortuous collaterals.
Figure 6. Dilated and tortuous collaterals in the epigastrium.
Figure 7. Chest X-ray showing pacemaker and pacing leads.
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morbidity and mortality.
The mechanism is believed to be mechanical stress
induced by transvenous leads, eliciting vascular wall
inflammation and fibrosis ultimately leading to venous
thrombosis and occlusion [11]. Although no clear risk
factors have been identified, several predictors of venous
occlusion in this setting have been reported as shown in
Table 1 [12,13]. On the other hand, long-term antic-
oagulation therapy seems to offer a protective effect [13].
No significant differences was observed between obstruc-
tion and non-obstruction groups in terms of age, sex,
cardiothoracic ratio, left atrial dimension, left ventricular
ejection fraction, baseline heart diseases for indication
of pacemaker implantation, or number and body size of
pacing leads [5]. Da Costa et al showed that previous
use of a temporary pacemaker and left ventricular
ejection fraction of 0.40 or less increased the risk
venous thrombosis 6 months after permanent pacemaker
insertion [14].
Another recently published study, looking at 100 con-
secutive patients for elective permanent transvenous
pacemaker, did not find any significant difference between
two groups in the incidence of venous abnormalities
according to the route of entry, the lead insulation or the
total number of the implanted leads [6].
Data regarding treatment options for SVCO are limited.
Contrary to the treatment of SVCO caused by malignant
tumors, treatment for benign causes of superior vena cava
obstruction is often protracted, punctuated by multiple
episodes of recurrences. These causes include arterio-
venous shunt, central lines and cardiac pacing wires.
Venous angioplasty and stenting in these patients are often
repeated, with cumulative patency approaching 80% at
2 years [15,16].
In cases related to cardiac pacing wires, removal of the
device is not only undesirable [in view of the cardiac
arrhythmia], but it is also often impossible and may not
relieve the symptoms. The leads, which are insulated by
silicon, are covered by endothelium and become incor-
porated into the vascular wall[ 4 ] .T h ep a c i n gw i r e sc a n
also become incorporated into the heart chambers,
making removal both difficult and sometimesdangerous.
Thrombosis can also occur along these wires leading to
stenoses and occlusions of the great veins [17]. Trauma to
the vessel wall during insertion, infection and dual
chamber systems are thought to be the predisposing
factors [9].
Various modalities of treatment that can be considered
include long-term anticoagulation as adopted in our case,
thrombolytic therapy, surgical intervention, percutaneous
transluminal balloon venoplasty and metallic stent inser-
tion. Options depend on the duration, extent, and site of
venous occlusion as well as the accompanying symptoms
[4]. A recent review by Bracke et al, looking at the evidence
base for lead extraction, concluded that there is no
evidence to suggest that properly abandoned leads are a
risk factor for venous occlusion and they should not be
routinely extracted [18].
Conclusion
SVCO in patients with transvenous pacing leads, although
rare, is a well recognized complication. SVCO can interfere
with intravenously administered therapy, monitoring of
central venous pressure and revision of a pacemaker lead.
With growing elderly population and increasing number
of procedures performed, more and more people with
permanent pacemaker are likely to be encountered in
clinical practice. One should carefully look for throm-
boembolic complications during follow-up in patients
with transvenous pacemaker leads, as it has implications
for future management and carries significant morbidity
and mortality.
Abbreviation
SVCO, Superior vena cava obstruction.
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Table 1. Risk Factors for Pacing lead induce venous thrombosis [12,13]
1. History of device upgrade.
2. Use of temporary endocardial pacemaker wires before the implantation
of a permanent device.
3. Presence of multiple endocardial leads.
4. Retention of severed leads.
5. Lead infection.
6. Use of dual coil leads.
7. Hormone therapy.
8. History of venous thrombosis.
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